Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
12.40
-0.42 (-3.28%)
At close: Feb 4, 2026, 4:00 PM EST
12.10
-0.30 (-2.42%)
After-hours: Feb 4, 2026, 5:41 PM EST

Vor Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
515138153437433-
Market Cap Growth
203.38%-9.38%-65.05%0.75%--
Enterprise Value
34710829341225-
Last Close Price
12.4022.2045.00133.00232.40-
PB Ratio
-1.431.011.742.00-
P/TBV Ratio
-1.431.011.742.00-
Debt / Equity Ratio
0.000.330.240.160.080.38
Quick Ratio
9.054.948.8117.5520.434.76
Current Ratio
9.165.199.0418.0621.124.81
Return on Equity (ROE)
--94.52%-58.74%-39.45%-52.09%-155.02%
Return on Assets (ROA)
-144.27%-44.42%-31.67%-21.55%-27.09%-63.23%
Return on Capital Employed (ROCE)
-214.30%-97.50%-69.00%-32.60%-29.70%-66.00%
Earnings Yield
-475.78%-84.57%-77.25%-21.09%-15.90%-
FCF Yield
-28.10%-72.25%-66.44%-21.44%-16.86%-
Buyback Yield / Dilution
-66.44%-2.25%-69.88%-18.30%-15547.86%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q